×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Loan Against Mutual Fund
Apply Now
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Budget 2026
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
PF
Forum
Videos
you are here:
Home
News
Santa rally? Three midcap stocks to consider buying on Tuesday
Private sector filling up the vacuum in healthcare facilities: Wockhardt
Aim to become a research-based co in 10 years; no plans to sell assets: Wockhardt
Hindustan Tin Works expect to cross Rs 300 crore topline in FY18
Will continue to do well in UK & Indian markets: Wockhardt
Cash ban, Brexit weigh heavy; expect normalcy in Q4: Wockhardt
No scope of US intervention in Indian pharma cos: Wockhardt
Pharma sector sales down 10-12%, pain to ease by Jan: Wockhardt
CP Pharma under FDA lens, will reply in 3 weeks: Wockhardt Chief
Wockhardt receives US FDA's establishment inspection report
Aim is to prevent rampant use of antibiotics: P Lilladher
R&D tax deduction unlikely to impact Wockhardt: CEO
See double-digit sales growth across markets in FY17: Wockhardt
All 9 USFDA observations will be resolved in 3 months: Wockhardt
Will not do any out-licensing in near-term: Wockhardt
Eye 15-20% revenue growth from US biz: Wockhardt
No grave observations made in USFDA Waluj visit: Wockhardt
Meet the Khorakiwalas: Gen-Next promoters of Wockhardt
See capex of Rs 500cr in next 3-4 yrs: Wockhardt Hospitals
Will take 2-2.5 yrs for phase-3 clinical trails: Wockhardt
India's pharma industry seeing rapid growth: Wockhardt
Need to be watchful of FDA import alert pattern: Dandekar
Taking corrrective measures on regulatory issues: Wockhardt
Q2 earnings hit by recent regulatory actions: Wockhardt
PAT boost on low debt-equity, high interest: Wockhardt
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio